HOME › DRUGS › ETIRINOTECAN PEGOL
ACTIVE SUBSTANCE / INN

ETIRINOTECAN PEGOL

Brand name(s): Onzeald
EMA LISTED
REFUSED
Breast Neoplasms
ACTIVE SUBSTANCE
Etirinotecan Pegol
REGULATORS
EMA
SPONSORS / MAH
Nektar Therapeutics UK Limited
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
OnzealdNektar Therapeutics UK LimitedRefusedBreast Neoplasms

FULL INTELLIGENCE ON ETIRINOTECAN PEGOL

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →